These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31881206)

  • 1. MicroRNA-200c-3p inhibits proliferation and migration of renal artery endothelial cells by directly targeting ZEB2.
    Liu Y; Jiang Y; Li W; Han C; Zhou L; Hu H
    Exp Cell Res; 2020 Feb; 387(2):111778. PubMed ID: 31881206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
    Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA and mRNA analysis of angiotensin II-induced renal artery endothelial cell dysfunction.
    Liu Y; Jiang Y; Li W; Han C; Qi Z
    Exp Ther Med; 2020 Jun; 19(6):3723-3737. PubMed ID: 32346437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
    He J; Wang J; Li S; Li T; Chen K; Zhang S
    Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers.
    Duan W; Tang S; Gao L; Dotts K; Fink A; Kalvala A; Aguila B; Wang QE; Villalona-Calero MA
    Sci Rep; 2021 Feb; 11(1):4420. PubMed ID: 33627769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2.
    Gao HB; Gao FZ; Chen XF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5149-5157. PubMed ID: 31298368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
    Xie R; Tang J; Zhu X; Jiang H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
    [No Abstract]   [Full Text] [Related]  

  • 10. miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
    Lu YM; Shang C; Ou YL; Yin D; Li YN; Li X; Wang N; Zhang SL
    Med Oncol; 2014 Aug; 31(8):134. PubMed ID: 25052237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 and FOXP3 jointly inhibit the migration and invasion of colorectal cancer cells by regulating ZEB2 expression.
    Yang LP; Lin Q; Mu XL
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6131-6138. PubMed ID: 31364113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fine tuning scheme of miR-200c in modulating lung cell redox homeostasis.
    Wu YH; Lin HR; Lee YH; Huang PH; Wei HC; Stern A; Chiu DT
    Free Radic Res; 2017 Jun; 51(6):591-603. PubMed ID: 28675952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma.
    Zhang J; Zhang H; Qin Y; Chen C; Yang J; Song N; Gu M
    Ann Transl Med; 2019 Apr; 7(7):141. PubMed ID: 31157262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc Finger E-Box Binding Protein 2 (ZEB2) Suppress Apoptosis of Vascular Endothelial Cells Induced by High Glucose Through Mitogen-Activated Protein Kinases (MAPK) Pathway Activation.
    Wang LJ; Wu ZH; Zheng XT; Long JY; Dong YM; Fang X
    Med Sci Monit; 2017 May; 23():2590-2598. PubMed ID: 28551696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
    Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
    Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
    Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
    Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC).
    Chen J; Zhong Y; Li L
    J Transl Med; 2020 Feb; 18(1):69. PubMed ID: 32046742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
    Wang S; Zhang G; Zheng W; Xue Q; Wei D; Zheng Y; Yuan J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB2-AS1 regulates the expression of TAB3 and promotes the development of colon cancer by adsorbing microRNA-188.
    Li YL; Zhang XX; Yao JN; Gao B; Gao SL; Wang CF; Zhou HN; Zhang LF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4180-4189. PubMed ID: 32373954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma.
    Wu J; Cao J; Li X; Wu B; Zhang S
    Arch Oral Biol; 2020 Aug; 116():104732. PubMed ID: 32445972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.